Woodford E M, Wilson K A, Marriott J F
The Pharmacy Practice Research Group, School of Pharmacy, Aston University, Birmingham B4 7ET, UK.
J Hosp Infect. 2004 Nov;58(3):193-9. doi: 10.1016/j.jhin.2004.06.026.
In recent years, there have been increasing recommendations for multidisciplinary collaboration between clinical pharmacists and medical microbiologists in an attempt to control the quality (and quantity) of antibiotic prescribing. A questionnaire addressing the utilization of antibiotic prescribing controls was sent to the chief pharmacist and medical microbiologist in UK NHS hospitals. Responses were received from both the chief pharmacist and the medical microbiologist employed in the same hospital from 83 hospitals (a 30% response rate from two independent studies). A high level of disagreement and poor awareness was identified between the interprofessional staff groups regarding the existence of antibiotic formulary (with disagreement between the two groups, or not known by one or both respondents, in 46% of the paired hospitals, N = 38) and guideline documents (13%, N = 11), performance of antibiotic prescribing audits (40%, N = 33), and whether pharmacists (52%, N = 43) and medical microbiologists (77%, N = 64) monitored physician compliance with antibiotic prescribing control documents. This study has identified poor knowledge of the existence of basic antibiotic prescribing control mechanisms and the role of professional colleagues. It is suggested that there is some way to go before 'Agenda for Change' principles of flexible and collaborative roles are met.
近年来,为了控制抗生素处方的质量(和数量),越来越多的人建议临床药剂师和医学微生物学家开展多学科合作。一份关于抗生素处方控制利用情况的调查问卷被发送给了英国国民健康服务体系(NHS)医院的首席药剂师和医学微生物学家。来自83家医院的同一家医院的首席药剂师和医学微生物学家都给出了回复(两项独立研究的回复率为30%)。在跨专业工作人员群体之间,关于抗生素处方集的存在(在46%的配对医院中,两组之间存在分歧,或者一方或双方受访者不知道,N = 38)、指南文件(13%,N = 11)、抗生素处方审核的执行情况(40%,N = 33),以及药剂师(52%,N = 43)和医学微生物学家(77%,N = 64)是否监测医生对抗生素处方控制文件的遵守情况,存在高度分歧和认识不足。这项研究发现,人们对基本抗生素处方控制机制的存在以及专业同事的作用了解甚少。有人认为,在实现“变革议程”中灵活协作角色的原则之前,还有很长的路要走。